The possible enhancement of parvovirus vaccination on the mortality rate of diseased dogs.
A survey was conducted by using questionnaires dealing with morbidity and mortality of young dogs. Seventy-one clinical evaluations of diseased dogs were included in this survey. The cases were divided into 3 groups according to their vaccination history: 1. dogs vaccinated with the parvovirus and distemper live modified vaccine; 2. dogs vaccinated with the killed parvovirus vaccine; 3. non-vaccinated dogs. Statistical analysis of the information obtained by analyzing the questionnaires gave the following results: The survival rate of the non-vaccinated and killed parvovirus vaccine-vaccinated dogs was significantly higher than that of the dogs which were vaccinated by the live modified vaccine. No such difference was encountered between groups 2 and 3. This finding, once more, supports the notion that the live modified parvovirus vaccine may have an immunosuppressive property.
Brenner
J
J
Markus
R
R
Klopfer-Orgad
U
U
Trainin
Z
Z
D000818:Animals; D004283:Dog Diseases / Q000401:mortality*; D004285:Dogs; D007108:Immune Tolerance; D010321:Parvoviridae / Q000276:immunology*; D011795:Surveys and Questionnaires; D014613:Vaccines, Attenuated / Q000009:adverse effects; D015164:Vaccines, Inactivated; D014765:Viral Vaccines / Q000009:adverse effects*
D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014765:Viral Vaccines